acromegaly

Crinetics Crinetics HQ Crinetics headquarters San Diego
Pharma

Crinetics breaks commercial barrier with Palsonify FDA nod

After nearly two decades in the endocrine scene, Crinetics is making its market debut with approval for a new oral drug in a rare hormone disorder.
Fraiser Kansteiner Sep 25, 2025 5:30pm
Image of a neon sign with the word no lit up next to an unlit yes

FDA stymies Camurus' drug over 3rd-party manufacturing issues

Oct 22, 2024 9:53am
acromeagly awarness

Crinetics rolls out new acromegaly disease treatment campaign

Aug 9, 2024 9:35am